Research programme: toll-like receptor 7 modulators - Telormedix

Drug Profile

Research programme: toll-like receptor 7 modulators - Telormedix

Alternative Names: TMX-202; TMX-302; TMX-30X

Latest Information Update: 20 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of California, San Diego
  • Developer Foamix; Telormedix; University of California, San Diego
  • Class Small molecules
  • Mechanism of Action Toll-like receptor 7 agonists; Toll-like receptor 7 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Autoimmune disorders; Skin cancer

Most Recent Events

  • 12 Sep 2013 Molecular Profiles has been acquired by Columbia Laboratories
  • 12 Mar 2013 Preclinical development is ingoing in Skin cancer and Autoimmune disorders
  • 04 Jun 2012 Preclinical development is ongoing in Skin cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top